Literature DB >> 8387791

[Ovarian tumor with hepatoid differentiation. Discussion and review of the literature. Report of a case].

J Badreddine1, Y Rabouille, J F Heron, A M Mandard.   

Abstract

One case of hepatoid carcinoma of the ovary is described, and a review of the literature is performed. This tumor is now considered as a variety of common epithelial tumor of the ovary and must be distinguished from other ovarian-neoplasms, especially from hepatoid yolk sac tumors.

Entities:  

Mesh：

Year:  1993        PMID： 8387791

Source DB:  PubMed          Journal:  Ann Pathol        ISSN： 0242-6498            Impact factor:   0.407


  6 in total

1.  Hepatoid carcinoma of the ovary: A case report and review of the literature.

Authors:  Xin-Li Liu; Xin Wang; Fu-Fan Zhu
Journal:  Oncol Lett       Date:  2012-08-24       Impact factor: 2.967

2.  alpha-Fetoprotein-producing adenocarcinoma of the pancreas presenting focal hepatoid differentiation.

Authors:  S Tanno; T Obara; T Fujii; T Izawa; Y Mizukami; Y Saitoh; H Ura; Y Kohgo
Journal:  Int J Pancreatol       Date:  1999-08

3.  Hepatoid carcinoma of the ovary: A case report and review of the literature.

Authors:  Laura K Randolph; Maeve K Hopkins; Michael P Hopkins; Daniel A Wasdahl
Journal:  Gynecol Oncol Rep       Date:  2015-06-18

4.  Hepatoid carcinoma of the ovary - A case report and literature review.

Authors:  Ana Karla Uribe Rivera; M Alvarez Larraondo; L Taxa Rojas; M Bravo Taxa; A Zevallos Cardenas
Journal:  Gynecol Oncol Rep       Date:  2020-04-01

5.  A case report of Hepatoid Carcinoma of the Ovary with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy without systemic adjuvant therapy.

Authors:  Samer A Naffouje; Richard R Anderson; George I Salti
Journal:  Int J Surg Case Rep       Date:  2016-08-17

6.  Extra-Hepatic Hepatoid Carcinomas in Female Reproductive System: Three Case-Reports with a Literature Review.

Authors:  Yao Liu; Ruiqi Zhou; Shourong Wang; Guiyu Zhang
Journal:  Cancer Manag Res       Date:  2021-02-17       Impact factor: 3.989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.